Future needs for informed consent in stem cell clinical trials in neurodegenerative diseases
Main Authors: | Natalie Hellmers, Yaa Obeng-Aduasare, Inmaculada de Melo-Martín, Claire Henchcliffe |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2016-01-01
|
Series: | Neural Regeneration Research |
Online Access: | http://www.nrronline.org/article.asp?issn=1673-5374;year=2016;volume=11;issue=1;spage=83;epage=85;aulast=Hellmers |
Similar Items
-
Coenzyme Q10 effects in neurodegenerative disease
by: Meredith Spindler, et al.
Published: (2009-11-01) -
The meaning and need for informed consent in research
by: Liesegang Thomas
Published: (2007-01-01) -
Informed Consent in Clinical Trials Using Stem Cells: Suggestions and Points of Attention from Informed Consent Training Workshops in Japan
by: M Kusunose, et al.
Published: (2015-09-01) -
Informed consent and clinical trials.
by: S P Kalantri
Published: (2004-01-01) -
Quality of informed consent in clinical trials
by: Anna Zagaja
Published: (2020-03-01)